氯贝丁酯给予人体受试者后的血浆浓度及生物利用度。 - Suppr | 超能文献

Plasma concentrations and bioavailability of clofibrate after administration to human subjects.

作者信息

Chasseaud L F, Cooper A J, Saggers V H

出版信息

J Clin Pharmacol. 1974 Jul;14(7):382-6. doi: 10.1002/j.1552-4604.1974.tb01415.x.

DOI:10.1002/j.1552-4604.1974.tb01415.x

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Plasma concentrations and bioavailability of clofibrate after administration to human subjects.氯贝丁酯给予人体受试者后的血浆浓度及生物利用度。

J Clin Pharmacol. 1974 Jul;14(7):382-6. doi: 10.1002/j.1552-4604.1974.tb01415.x.

2

Plasma concentrations and bioavailability of clofibric acid from its calcium salt in humans.氯贝酸钙在人体中的血浆浓度及氯贝酸的生物利用度。

J Pharm Sci. 1977 Nov;66(11):1638-9. doi: 10.1002/jps.2600661138.

3

Biopharmaceutic evaluation of etofylline clofibrate and its drug formulation.氯贝酸乙氧茶碱及其药物制剂的生物药剂学评价。

Arzneimittelforschung. 1980;30(11b):2020-3.

4

[Pharmacokinetics of a combination of magnesium-chlorophenoxy-isobutyrate and meso-inositol hexanicotinate].[氯苯氧异丁酸镁与肌醇六烟酸酯组合的药代动力学]

Acta Med Austriaca. 1977;4(3):120-4.

5

The effect of colestipol hydrochloride on the bioavailability and pharmacokinetics of clofibrate.盐酸考来烯胺对氯贝丁酯生物利用度和药代动力学的影响。

J Clin Pharmacol. 1979 Nov-Dec;19(11-12):721-5. doi: 10.1002/j.1552-4604.1979.tb01642.x.

6

Serum clofibrate concentrations in patients on continuous medication.持续用药患者的血清氯贝丁酯浓度。

Pharmacology. 1974;12(3):144-51. doi: 10.1159/000136532.

7

[Bioavailability of clofibrate. Comparative studies on Regelan and Bioscleran].

MMW Munch Med Wochenschr. 1977 Sep 2;119(35):1109-10.

8

Clofibrate kinetics after single and multiple doses.单剂量和多剂量氯贝丁酯的动力学

Clin Pharmacol Ther. 1978 Oct;24(4):432-8. doi: 10.1002/cpt1978244432.

9

Clofibrate disposition in renal failure and acute and chronic liver disease.氯贝丁酯在肾衰竭以及急慢性肝病中的处置情况。

Eur J Clin Pharmacol. 1979 Jun 12;15(5):341-7. doi: 10.1007/BF00558438.

10

Pharmacokinetics of clofibrate and chlorophenoxy isobutyric aicd. I. Cross-over studies on human volunteers.氯贝丁酯和氯苯氧基异丁酸的药代动力学。I. 对人类志愿者的交叉研究。

Acta Pharmacol Toxicol (Copenh). 1975 Apr;36(4):353-65. doi: 10.1111/j.1600-0773.1975.tb00802.x.

引用本文的文献

1

Drug Concentration Asymmetry in Tissues and Plasma for Small Molecule-Related Therapeutic Modalities.小分子相关治疗模式的组织和血浆中药物浓度的不对称性。

Drug Metab Dispos. 2019 Oct;47(10):1122-1135. doi: 10.1124/dmd.119.086744. Epub 2019 Jul 2.

2

A standard approach to compiling clinical pharmacokinetic data.一种汇编临床药代动力学数据的标准方法。

J Pharmacokinet Biopharm. 1981 Feb;9(1):59-127. doi: 10.1007/BF01059343.

3

A GLC method for estimation of chlorophenoxyisobutyric acid in plasma. Pharmacokinetics of a single oral dose of clofibrate in man.

Eur J Clin Pharmacol. 1975 Aug 14;8(6):433-7. doi: 10.1007/BF00562318.